Invasive fungal infections caused by Candida and Malassezia species in the neonatal intensive care unit

Premature infants in the neonatal intensive care unit (NICU) are at particular risk of invasive fungal infections, and unfortunately, the incidence of fungal septicemia appears to be increasing. Invasive infections caused by species of Candida or Malassezia have been documented in the NICU and are o...

Full description

Saved in:
Bibliographic Details
Published inAdvances in neonatal care Vol. 6; no. 2; p. 68
Main Author Devlin, Roni K
Format Journal Article
LanguageEnglish
Published United States 01.04.2006
Subjects
Antifungal Agents - pharmacology
Antifungal Agents - therapeutic use
Candidiasis - diagnosis
Candidiasis - drug therapy
Candidiasis - microbiology
Candidiasis - prevention & control
Fungemia - diagnosis
Fungemia - drug therapy
Fungemia - microbiology
Fungemia - prevention & control
Humans
Infant, Newborn
Infant, Premature
Intensive Care Units, Neonatal
Malassezia
Mycoses - diagnosis
Mycoses - drug therapy
Mycoses - microbiology
Mycoses - prevention & control
Online AccessGet more information

Cover

More Information
Summary:Premature infants in the neonatal intensive care unit (NICU) are at particular risk of invasive fungal infections, and unfortunately, the incidence of fungal septicemia appears to be increasing. Invasive infections caused by species of Candida or Malassezia have been documented in the NICU and are often associated with significant morbidity and mortality. Controversies regarding the diagnosis, treatment, and prevention of such diseases exist. The purpose of this review is to describe the epidemiology, clinical manifestations, diagnostic techniques, treatment, and prevention of invasive infection due to Candida and Malassezia species in the neonatal intensive care setting.
ISSN:1536-0903
1536-0911
DOI:10.1016/j.adnc.2006.01.005